ABBV price target
AbbVie Inc. · end-of-day data as of Oct 16, 2026
AbbVie Inc.
$285.42+10.7%
Buy · 30 analystsPT $281.54 -1.4%
The average price target of the 17 analyst firms that published one in the last 12 months is $281.54 for ABBV, 1.4% below the last close of $285.42 on Oct 16, 2026. Targets range from $217.17 to $319.82, with a median of $289.36. Rating consensus: Buy.
Summary
- Target upside-1.4%
- ConsensusBuy
Analyst price targets
Low$217.17
Average$281.54
Median$289.36
High$319.82
Upside-1.4%
17 firms with a target in the last 12 months · last close $285.42 · as of Oct 16, 2026
Morgan Stanley$2622025-12-12
HSBC$2602025-12-10
Piper Sandler$2852025-11-05
Raymond James$2422025-11-03
Guggenheim$2382025-10-20
Raymond James$2462025-10-17
RBC Capital$2542026-02-24
Barclays$2692026-02-19
UBS$2272026-02-05
Evercore ISI$2232026-02-04
Goldman Sachs$2172026-01-28
Berenberg Bank$2692026-01-20
+2 more
Piper Sandler$2872026-02-18
Evercore ISI$2302026-05-15
Piper Sandler$2972026-05-14
Morgan Stanley$2732026-04-30
Piper Sandler$2912026-04-23
Canaccord Genuity$2592026-04-20
Guggenheim$2412026-04-10
+1 more
Piper Sandler$2962026-08-20
Wells Fargo$2992026-08-17
Wolfe Research$3012026-08-13
Guggenheim$2852026-08-04
Canaccord Genuity$2822026-08-03
Morgan Stanley$2932026-08-03
+11 more
Cantor Fitzgerald$2892026-10-08
Morgan Stanley$3082026-10-07
Scotiabank$3202026-10-06
HSBC$3182026-09-10
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets
Strong buy 8 · Buy 16 · Hold 5 · Sell 0 · Strong sell 1